Authors: Ruan S, Wang S, Jiang Y.
DOI: 10.3389/fmed.2025.1707913
Abstract Summary
Researchers identified CD247 as a crucial gene linking lupus (SLE) to lymphoma (DLBCL) risk. Using machine learning, they found high CD247 expression enhances anti-tumor immunity through CD8+ T cells and inhibits lymphoma cell growth while promoting cancer cell death. This discovery reveals shared immune mechanisms between the two diseases and potential therapeutic targets.
Why Brain? đź§
Study identifies CD247 gene linking lupus to lymphoma risk, showing it regulates immune response and cancer cell death, potentially explaining why lupus patients develop this blood cancer.
License: CC BY.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.



